BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8508481)

  • 1. Conformational recognition of RA-XII by 80S ribosomes: a differential line broadening study in 1H NMR spectroscopy.
    Morita H; Yamamiya T; Takeya K; Itokawa H; Sakuma C; Yamada J; Suga T
    Chem Pharm Bull (Tokyo); 1993 Apr; 41(4):781-3. PubMed ID: 8508481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structures and conformations of metabolites of antitumor cyclic hexapeptides, RA-VII and RA-X.
    Itokawa H; Saitou K; Morita H; Takeya K; Yamada K
    Chem Pharm Bull (Tokyo); 1992 Nov; 40(11):2984-9. PubMed ID: 1477912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New cytotoxic bicyclic hexapeptides, RA-XXIII and RA-XXIV, from Rubia cordifolia L.
    Lee JE; Hitotsuyanagi Y; Fukaya H; Kondo K; Takeya K
    Chem Pharm Bull (Tokyo); 2008 May; 56(5):730-3. PubMed ID: 18451569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New antitumor bicyclic hexapeptides, RA-XI, -XII, -XIII and -XIV from Rubia cordifolia.
    Morita H; Yamamiya T; Takeya K; Itokawa H
    Chem Pharm Bull (Tokyo); 1992 May; 40(5):1352-4. PubMed ID: 1394660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RA-XXV and RA-XXVI, Bicyclic Hexapeptides from Rubia cordifolia L.: Structure, Synthesis, and Conformation.
    Hitotsuyanagi Y; Hirai M; Odagiri M; Komine M; Hasuda T; Fukaya H; Takeya K
    Chem Asian J; 2019 Jan; 14(1):205-215. PubMed ID: 30393964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solution forms of an antitumor cyclic hexapeptide, RA-VII in dimethyl sulfoxide-d6 from nuclear magnetic resonance studies.
    Itokawa H; Morita H; Takeya K
    Chem Pharm Bull (Tokyo); 1992 Apr; 40(4):1050-2. PubMed ID: 1525934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two antitumour bicyclic hexapeptides from Rubia cordifolia.
    Takeya K; Yamamiya T; Morita H; Itokawa H
    Phytochemistry; 1993 Jun; 33(3):613-5. PubMed ID: 7763798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of [Gly-1]RA-VII, [Gly-2]RA-VII, and [Gly-4]RA-VII. Glycine-containing analogues of RA-VII, an antitumor bicyclic hexapeptide from Rubia plants.
    Hitotsuyanagi Y; Hasuda T; Aihara T; Ishikawa H; Yamaguchi K; Itokawa H; Takeya K
    J Org Chem; 2004 Mar; 69(5):1481-6. PubMed ID: 14987000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aza-cycloisodityrosine analogue of RA-VII, an antitumor bicyclic hexapeptide.
    Hitotsuyanagi Y; Miyazawa A; Hinosawa TA; Nakagawa Y; Hasuda T; Takeya K
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6728-31. PubMed ID: 24268554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation, structure determination, and synthesis of allo-RA-V and neo-RA-V, RA-series bicyclic peptides from Rubia cordifolia L.
    Hitotsuyanagi Y; Odagiri M; Kato S; Kusano J; Hasuda T; Fukaya H; Takeya K
    Chemistry; 2012 Mar; 18(10):2839-46. PubMed ID: 22298232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rubipodanin B, a New Cytotoxic Cyclopeptide from Rubia podantha.
    Hu YY; Feng L; Wang J; Zhang XJ; Wang Z; Tan NH
    Chem Biodivers; 2019 Jan; 16(1):e1800438. PubMed ID: 30334345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbial transformations of natural antitumor agents XXII: Conversion of bouvardin to O-desmethylbouvardin and bouvardin catechol.
    Petroski RJ; Bates RB; Linz GS; Rosazza JP
    J Pharm Sci; 1983 Nov; 72(11):1291-4. PubMed ID: 6644590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of a bis(cycloisodityrosine) analogue of RA-VII, an antitumor bicyclic hexapeptide.
    Lee JE; Hitotsuyanagi Y; Nakagawa Y; Kato S; Fukaya H; Takeya K
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6458-61. PubMed ID: 18993061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Per-N-methylated analogues of an antitumor bicyclic hexapeptide RA-VII.
    Hitotsuyanagi Y; Lee JE; Kato S; Kim IH; Kohashi H; Fukaya H; Takeya K
    Bioorg Med Chem; 2011 Apr; 19(7):2458-63. PubMed ID: 21382716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational analysis of [n-demethyl-Tyr(OCH3)-3]RA-VII, conformationally restricted model approach.
    Itokawa H; Saitou K; Morita H; Takeya K
    Chem Pharm Bull (Tokyo); 1991 Aug; 39(8):2161-3. PubMed ID: 1797443
    [No Abstract]   [Full Text] [Related]  

  • 16. RA-dimer B, a New Dimeric RA-series Cyclopeptide Incorporating Two Different Types of Cycloisodityrosine Units, from Rubia cordifolia L.
    Hitotsuyanagi Y; Tsuchiya T; Ohata M; Yoshida A; Fukaya H; Park HS; Takeya K; Kawahara N
    Chem Asian J; 2016 Dec; 11(23):3389-3397. PubMed ID: 27863076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on RA derivatives. V. Synthesis and antitumor activity of Ala2-modified RA-VII derivatives.
    Itokawa H; Kondo K; Hitotsuyanagi Y; Isomura M; Takeya K
    Chem Pharm Bull (Tokyo); 1993 Aug; 41(8):1402-10. PubMed ID: 8403089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of [L-Ala-1]RA-VII, [D-Ala-2]RA-VII, and [D-Ala-4]RA-VII by epimerization of RA-VII, an antitumor bicyclic hexapeptide from Rubia plants, through oxazoles.
    Hitotsuyanagi Y; Sasaki S; Matsumoto Y; Yamaguchi K; Itokawa H; Takeya K
    J Am Chem Soc; 2003 Jun; 125(24):7284-90. PubMed ID: 12797802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solution forms of antitumor cyclic pentapeptides with 3,4-dichlorinated proline residues, astins A and C, from Aster tataricus.
    Morita H; Nagashima S; Takeya K; Itokawa H
    Chem Pharm Bull (Tokyo); 1995 Aug; 43(8):1395-7. PubMed ID: 7553986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on antitumor cyclic hexapeptides RA obtained from rubiae radix, rubiaceae. VI. Minor antitumor constituents.
    Itokawa H; Takeya K; Mori N; Sonobe T; Mihashi S; Hamanaka T
    Chem Pharm Bull (Tokyo); 1986 Sep; 34(9):3762-8. PubMed ID: 3815597
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.